United Therapeutics Corp (FRA:UTH)
€ 245.3 4.6 (1.91%) Market Cap: 10.88 Bil Enterprise Value: 8.92 Bil PE Ratio: 12.50 PB Ratio: 2.19 GF Score: 89/100

United Therapeutics Corp at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 08, 2021 / 01:50PM GMT
Release Date Price: €174 (-0.57%)
Tiago Felipe Fauth;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

All right. Welcome, everyone, to our 30th Annual Healthcare Conference. Credit Suisse. I'm Tiago Fauth, I'm a biotech analyst here at Credit Suisse, and we're joined today by United Therapeutics. We have Michael Benkowitz. We have Dewey, and we have James Edgemond as well.

I'm just going to hand it off to Dewey, so he can read some forward-looking statements, language and when we can jump right in.

Dewey Steadman
United Therapeutics Corporation - Head of IR

Thank you, Tiago, and good morning, everyone. Our remarks today may include forward-looking information about our business. Please see our SEC filings especially Forms 10-K and 10-Q for risks and uncertainties that could cause actual results to differ.

And with that, I'll turn it back over to you, Tiago.

Tiago Felipe Fauth;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

Perfect. As usual, we can kick it

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot